ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AgelessRx Named to Inc. Magazine's List of Fastest Growing Private Companies in America

Ann Arbor, MI – Inc. Magazine today revealed that AgelessRx, a pioneering longevity platform expanding access to science-backed anti-aging treatments, has been named to the prestigious Inc. 5000 list of America's fastest-growing private companies. This recognition highlights AgelessRx's exceptional growth trajectory as the company continues to revolutionize how individuals approach aging and healthspan optimization.

What is AgelessRx?

AgelessRx is a leading telemedicine platform focused on longevity science and healthspan improvement. The company provides accessible, evidence-based treatments that help individuals manage aging through scientifically-proven therapies including Metformin, NAD+ patches, Low Dose Naltrexone (LDN), Rapamycin, and GLP-1 medications. Operating entirely online, AgelessRx connects patients with US-licensed medical providers to deliver personalized longevity treatments directly to consumers' doors.

AgelessRx Inc. 5000 Achievement Details

The Inc. 5000 ranking provides a data-driven analysis of the most successful companies within America's most dynamic business segment - independent, entrepreneurial enterprises. Companies on the 2025 Inc. 5000 list are ranked according to their percentage revenue growth over three years, from 2021 to 2024. Previous Inc. 5000 honorees include household names like Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia, which gained their first national exposure through this prestigious recognition.

Revolutionary Impact on Longevity Healthcare

AgelessRx's inclusion on the Inc. 5000 list reflects the growing demand for accessible longevity treatments and the company's success in addressing a critical healthcare gap. AgelessRx has advanced as one of 40 global teams as a semi-finalist of the prestigious XPRIZE Healthspan competition, recognizing the company's mission to delay and reverse age-related decline.

Key AgelessRx differentiators include:

  • Science-Backed Treatments: Offering clinically validated longevity therapies including Metformin for diabetes prevention, NAD+ for cellular health, and Rapamycin for anti-aging 
  • Accessible Healthcare Model: 100% online platform eliminating traditional healthcare barriers 
  • Research Leadership: The PEARL Trial is the first large-scale intervention trial on longevity - and one of the first studies to show that low-dose, intermittent Rapamycin is safe for healthy adults 
  • Expert Medical Team: US-licensed providers specializing in longevity medicine 
  • Comprehensive Approach: Combining prescription treatments with biomarker testing and personalized consultations

Longevity Market Growth and Industry Impact

The longevity and anti-aging market represents one of healthcare's fastest-growing sectors, driven by increasing consumer awareness of preventive medicine and healthspan optimization. Only 20% of how people age is defined by genetics. Guided by the latest longevity research and a community of experts, AgelessRx is proud to play a leading role in discovering new, science-backed treatment options to make longevity science accessible.

Future Growth and Innovation

AgelessRx continues to expand its research initiatives and treatment offerings. The company's Applied Science team conducts ongoing clinical trials investigating the longevity benefits of various interventions, with results published in peer-reviewed journals. Recent studies include investigations into Rapamycin's effects on muscle mass, bone density, and periodontal health.

For more information about AgelessRx and its longevity treatments, visit agelessrx.com.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, visit www.inc.com/inc5000.

About AgelessRx

AgelessRx is at the forefront of the longevity revolution, offering clinically validated cutting-edge solutions and preventive treatments aimed at extending life expectancy and enhancing quality of life. AgelessRx also continues to advance the field of longevity science by conducting ongoing research and clinical trials. Through its online platform, AgelessRx provides easy access to innovative healthcare services, with an emphasis on customer satisfaction, affordability, and the pursuit of a future where extended healthspan is a reality for everyone.

Email:

 press@agelessrx.com 

Media Contact

Name
AgelessRx
Contact name
Anar Isman
Contact phone
650-503-9990
Contact address
2370 E Stadium Blvd #2049
City
Ann Arbor
State
MI
Zip
48104
Country
United States
Url
https://www.agelessrx.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.